According to Saili Medical's announcement, the company repurchased shares twice in 2024, totaling 3.977,700 shares, accounting for 1.76% of the total share capital. On May 9, 2026, the company disclosed its holdings reduction plan and plans to reduce its holdings by no more than 3.977,700 shares within 6 months and repurchase the shares already purchased. As of August 5, the company has not sold the aforementioned repurchased shares. There is a risk of uncertainty in reducing holdings, and the company will promptly fulfill its information disclosure obligations in accordance with regulations.

According to Saili Medical's announcement, the company repurchased shares twice in 2024, totaling 3.977,700 shares, accounting for 1.76% of the total share capital. On May 9, 2026, the company disclosed its holdings reduction plan and plans to reduce its holdings by no more than 3.977,700 shares within 6 months and repurchase the shares already purchased. As of August 5, the company has not sold the aforementioned repurchased shares. There is a risk of uncertainty in reducing holdings, and the company will promptly fulfill its information disclosure obligations in accordance with regulations.